Podcasts360

In this podcast, George Karpouzas, MD, talks about his study that evaluated the influence of distinct domains of rheumatoid arthritis (RA) disease activity, functional limitation, mood disturbance, as well as RA-specific knowledge and patients’ beliefs about medications on treatment adherence. More at: www.consultant360.com/rheumatology

A new subgroup analysis of the VOYAGER-PAD trial revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient with peripheral artery disease (PAD) at the time of revascularization is beneficial. In this podcast, William R. Hiatt, MD, provides insight into the analysis results. The topic is one he presented about during a late-breaking clinical trial session, “The Benefit...

In this podcast, Kristie Harris, PhD, discusses her findings on the association of physical activity, smoking, alcohol use, and caffeinated coffee consumption with Takotsubo syndrome. Does the use of psychostimulants play a role in the syndrome’s pathophysiology? Here is what she says. For more, click here: www.consultant360.com/cardiology

In this podcast, Dominick J. Angiolillo, MD, PhD, provides insight into a new analysis of the TWILIGHT trial that he and his colleagues performed among high-risk patients with diabetes. It was a topic he discussed during ACC.20/WCC Virtual, when he presented the session, “Ticagrelor With and Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention:...

Nolan Williams, MD, on the SAINT Depression Trial by Consultant360

In this podcast, Mark Pimentel, MD, talks about the American College of Gastroenterology's new clinical guideline on small intestinal bacterial overgrowth (SIBO), how the guideline attempts to clear up the controversies around diagnosis and treatment of SIBO, and more. More at: www.consultant360.com/gastroenterology

While researchers originally explored sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide (GLP)-1 receptor agonists for their impact on blood glucose, the two classes of agents were unexpectedly found to have cardiovascular benefits. In this podcast, Ralph Brindis, MD, MPH, interviews Laurence Sperling, MD, about implementing SGLT2 inhibitors and GLP-1 receptor agonists int...

In this podcast, George Karpouzas, MD, talks about his research on highly sensitive cardiac troponin-I and IgA antibodies against β-2 glycoprotein 1 in the setting of coronary atherosclerosis among patients with rheumatoid arthritis. More at: www.consultant360.com/rheumatology

In this podcast, George Karpouzas, MD, discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of inflammation on atherosclerosis among patients with rheumatoid arthritis. More at: www.consultan360.com/rheumatology

In this podcast, George Karpouzas, MD, talks about his study that evaluated whether biologic disease-modifying antirheumatic drugs reduce long-term risk of cardiovascular events in patients with rheumatoid arthritis, as well as their mechanism of action. More at: www.consultant360.com/rheumatology.

In this podcast, George Karpouzas, MD, talks about his study that evaluated the impact of inflammation, cardiac risk factors, duration of medication exposure, and their interactions on coronary plaque progression among patients with rheumatoid arthritis. More at: www.consultant360.com/rheumatology.

In this podcast, J. Antonio Aviña-Zubieta, MD, MSc, PhD, from the University of British Columbia, discusses his research on the overall risk and temporal trends of venous thromboembolism, deep vein thrombosis, and pulmonary embolism in patients with gout, as well as how rheumatologists can approach management. More at: www.consultant360.com/rheumatology

In this podcast, Dr Eiras discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has changed his practice. For more, visit www.consultant360.com/infectious-diseases.

In this podcast, Valerie Delpech, MBBS, MPH, speaks about her session at CROI 2020, which was focused on UK HIV epidemic and the programs that were implemented that helped reduce the number of HIV infections in the region. More at: www.consultant360.com/infectious-diseases

In this podcast, Veronique Morinville, MDCM, from Montreal Children's Hospital, talks about the latest NASPGHAN position paper on roles of endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) in the evaluation and treatment of chronic pancreatitis in children. More at: www.consultant360.com/gastroenterology

In this podcast, Gaurav Syal, MD, talks about his session at our Advances in Inflammatory Bowel Disease meeting, during which he spoke about the importance of dysplasia surveillance and how dysplasia should be tracked in the future. More at: www.consultant360.com/gastroenterology.

In this podcast, Ilya Kister, MD, discusses an article he wrote about the concept and applications of the multiple sclerosis disease severity score, introducing Herbert's Classification, and more. More at: www.consultant360.com/neurology

In this podcast, Melanie Taylor, MD, MPH, discusses her virtual session at CROI 2020, during which she talked about global trends in congenital syphilis, prevention of mother-to-child transmission, and why every pregnant women with syphilis should receive penicillin. More at: www.consultant360.com/infectious-diseases

In this podcast, Kevin Winthrop, MD, MPH, from Oregon Health & Science University, talks about how vaccinations affect individuals with immunocompromised immune systems, the challenges associated with vaccination, and what rheumatologists should know about vaccines in 2020. More at: www.consultant360.com/rheumatology

In this podcast, Shane Crotty, PhD, discusses his plenary session at CROI 2020, during which he talked about his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell repertoire. More at: www.consultant360.com/infectious-diseases

In this podcast, Paula Debroy, from the University of Texas at Houston, talks about the research she recently presented at CROI 2020. Her team's latest study investigated the relationships between frailty, sarcopenia, and nonalcoholic fatty liver disease in people with HIV. More at: www.consultant360.com/infectious-diseases

In this podcast, Dr Lee discusses the current state of affairs with the COVID-19 pandemic, what the United States can learn from other countries with high rates of COVID-19 cases, and more. For more podcasts like this, visit www.consultant360.com/infectious-diseases.

In this podcast, Daniel S. Fierer, MD, discusses his team's latest research on hepatitis C virus (HCV) reinfection rates among men who have sex with men (MSM) who have HIV and are treated in New York City. More at: www.consultant360.com/infectious-diseases

In this podcast, Erin D. Michos, MD, MHS, from Johns Hopkins University, answers our questions about her team's latest study on women who are training in cardiology, how women are represented in cardiology and its subspecialties, and more. More at: www.consultant360.com/cardiology

Dr Turchin discusses the findings of his recent study, which identified predictors and consequences of declining insulin therapy among patients with type 2 diabetes. He also explains how endocrinologists and related clinicians treating diabetes can address these areas and reach these patients. For more, visit www.consultant360.com/endocrinology.